FindTrial
Sign In

The microsampling therapeutic drug monitoring research of antibiotics in pediatric patients with infection

The microsampling therapeutic drug monitoring research of antibiotics in pediatric patients with infection

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200063053
Enrollment
Unknown
Registered
2022-08-29
Start date
2022-08-30
Completion date
Unknown
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bacterial infection

Interventions

Gold Standard:Venipuncture
Index test:dried&#32
blood&#32
spots&#32
and&#32
capillary&#32
microsamples

Sponsors

Children’s Hospital of Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: Children who are admitted to the ICU Department of the Children's Hospital Affiliated to Fudan University and who need to monitor the therapeutic concentration of vancomycin/meropenem/linezolid.

Exclusion criteria

Exclusion criteria: 1. The disease status of the child is not suitable for blood drug concentration monitoring; 2. The physiological condition (hematocrit) of the child is not within the validation range of the methodology (15%-40%); 3. The child received norvancomycin treatment within 3 days; 4. Clinicians and researchers believe that there are other situations that are not suitable for blood drug concentration monitoring or micro sampling; 5. The child or his guardian disagrees with the micro-sampling method.

Design outcomes

Primary

MeasureTime frame
the agreement of drug concentration;—

Countries

China

Contacts

Public ContactLi Zhiping

Children’s Hospital of Fudan University

zpli@fudan.edu.cn+86 13816880750

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026